Stephens Inc’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-8,752
Closed -$643K 1189
2020
Q2
$643K Buy
+8,752
New +$643K 0.01% 637